Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31064743 | 0.82 | SLC6A3 (0.40) | CYP19A1 | |
| SCHEMBL996860 | 0.82 | SLC6A3 (0.40) | CYP19A1 | |
| SCHEMBL29723671 | 0.82 | SLC6A3 (0.40) | CYP19A1 | |
| SCHEMBL3926283 | 0.82 | SLC6A3 (0.40) | CYP19A1 | |
| SCHEMBL29723645 | 0.82 | SLC6A3 (0.40) | CYP19A1 | |
| SCHEMBL601985 | 0.82 | CYP19A1 (0.38) | CYP19A1 | |
| SCHEMBL2000716 | 0.80 | CYP19A1 (0.36) | CYP19A1 | |
| SCHEMBL7741611 | 0.79 | CYP19A1 (0.36) | CYP19A1 | |
| SCHEMBL511962 | 0.78 | HSD11B1 (0.34) | CYP19A1 | |
| SCHEMBL4247813 | 0.78 | TSHR (0.38) | CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108473972-A | Drimenol synthase III | 弗门尼舍有限公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-102718759-A | Heterocyclic CETP inhibitors | BRISTOL MYERS SQUIBB CO | 2012-10-10 | — | — | CN | disclosed |
| CN-101675069-A | Method for producing fine chemicals | METANOMICS GMBH | 2010-03-17 | — | — | CN | disclosed |
| WO-2009120815-A2 | THERAPEUTIC COMPOSITIONS AND METHODS | BOSTON BIOCOM, LLC (US) | 2009-10-01 | — | — | WO | disclosed |
| CN-101528699-A | Heterocyclic cetp inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2009-09-09 | — | — | CN | disclosed |
| CN-101421412-A | Process for the production of fine chemicals | METANOMICS GMBH (DE) | 2009-04-29 | — | — | CN | disclosed |
| CN-101356161-A | Heterocyclic CETP inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2009-01-28 | — | — | CN | disclosed |
| CN-1795177-A | 1, 2, 4-substituted 1, 2, 3, 4-tetrahydro-and 1, 2 dihydro-quinolines and 1, 2, 3, 4-tetrahydro-quinoxaline derivatives as CETP inhibitors for the treatment of atherosclerosis and obesity | PFIZER PROD INC (US) | 2006-06-28 | — | — | CN | disclosed |
| EP-1583834-A1 | GENE EXPRESSION INDUCING FUSION PROTEIN AND METHOD FOR CONTROLLING GENE EXPRESSION INDUCTION | Millegen (FR) | 2005-10-12 | — | — | EP | disclosed |
| WO-2004067745-A1 | GENE EXPRESSION INDUCING FUSION PROTEIN AND METHOD FOR CONTROLLING GENE EXPRESSION INDUCTION | MILLEGEN (FR) | 2004-08-12 | — | — | WO | disclosed |